Skip To Main Content
Delphine Reuter on Muck Rack

Delphine Reuter

Brussels Capital
As seen in: The International Consortium of Investigative Journalists (ICIJ), El País, The Guardian, The Washington Post, USA Today, Salon, The Irish Times, The Seattle Times, Yahoo Sports Canada, ProPublica, Australian Financial Review and
Data journo @ICIJorg
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Delphine

Contact Delphine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Preguntas frecuentes sobre la investigación The Cancer Calculus

|
By Delphine Reuter, Joanna Robin, Jelena Cosic
| Salud Con Lupa Verified
¿Qué es Keytruda? ¿Por qué es tan caro? Los principales hallazgos de The Cancer Calculus y más. Ilustración: Chelsea Conrad / ICIJ ¿Qué es la investigación The Cancer Calculus?
Open in Who Shared Issue with article?

Sobre la investigación The Cancer Calculus

|
By Fergus Shiel Verified, Delphine Reuter
| Salud Con Lupa Verified
Cómo Merck mantiene el precio de su medicamento oncológico de venta récord, Keytruda, extremadamente alto, excluyendo a los pacientes y presionando a los sistemas de salud en todo el mundo. Ilustración: Chelsea Conrad/ICIJ Una investigación de un año del Consorcio Internacional de Periodistas de Investigación (ICIJ) revela cómo Merck & Co. ha mantenido el precio de su medicamento oncológico estrella, Keytruda, en niveles extraordinariamente altos, mientras disuade la entrada de competidores.
Open in Who Shared Issue with article?

Frequently asked questions about the Cancer Calculus investigation

|
By Delphine Reuter
| The International Consortium of Investigative Journalists (ICIJ)
The Cancer Calculus is a yearlong investigation by the International Consortium of Investigative Journalists that reveals how Merck & Co. keeps the price of its blockbuster cancer drug Keytruda extraordinarily high while stifling competition.
Open in Who Shared Issue with article?
See all 53 licensed articles (58 Total)